HRT Financial LP Invests $81.60 Million in HCA Healthcare, Inc. $HCA

HRT Financial LP acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, Holdings Channel.com reports. The institutional investor acquired 212,990 shares of the company’s stock, valued at approximately $81,596,000.

A number of other large investors have also made changes to their positions in HCA. Saudi Central Bank purchased a new stake in HCA Healthcare during the first quarter worth about $26,000. WPG Advisers LLC acquired a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $27,000. Ameriflex Group Inc. acquired a new position in HCA Healthcare during the second quarter worth $27,000. Chung Wu Investment Group LLC acquired a new stake in HCA Healthcare in the second quarter valued at $27,000. Finally, Clearstead Trust LLC raised its stake in shares of HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of research reports. Bank of America lifted their target price on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research report on Monday, October 27th. Sanford C. Bernstein reiterated a “market perform” rating and set a $417.00 target price on shares of HCA Healthcare in a report on Monday, October 27th. Robert W. Baird upped their price objective on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research report on Thursday. Morgan Stanley set a $425.00 price objective on HCA Healthcare in a research report on Monday, October 27th. Finally, Barclays lifted their price target on shares of HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $475.95.

HCA Healthcare Price Performance

Shares of HCA stock opened at $484.67 on Friday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The firm’s 50-day simple moving average is $465.59 and its 200-day simple moving average is $413.62. The firm has a market cap of $110.60 billion, a P/E ratio of 18.73, a PEG ratio of 1.42 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the firm posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is presently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.